PATENT CLAIM ANALYSIS

Application Number: 16035274
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "185100"]

Abstract:
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.

Claim (Index 3):
The method, according to  claim 1 , used to treat neurogenic edema.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.48936
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15511697', '12064923', '13908636', '13847275', '14727589']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6685337174083501
- 35 USC 102 Novelty (BERT): 0.5248133689374718
- Combined Prediction Score: 0.6541616825612624
- Mean Citation Score: 217.598952
- Max Citation Score: 270.92593
- Similarity Product: 163.19399318572582

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test